IBJNews

Q&A

Back to TopCommentsE-mailPrintBookmark and Share

Amy Zucker is president of Indianapolis-based Synergy Marketing Group. Her firm was recently hired by Indianapolis-based ImmuneWorks Inc. to use a new website and search-engine optimization to help recruit patients for a Phase 1 trial of ImmuneWorks experimental medicine for idiopathic pulmonary fibrosis, or IPF. The Web strategy is a new wrinkle on patient recruitment—in addition to the traditional partnerships with disease specialists at academic medical centers—which Zucker hopes leads to lower costs and faster clinical trials. Phase 1 clinical trials cost nearly $16,000 per patient.

IBJ: Your company has worked for life sciences firms doing commercialization work but never clinical-trial recruitment. How did you get together with ImmuneWorks on this project?

A:  I’ve known [ImmuneWorks CEO] Wade Lange for many years. He recognized that if he’s going to market with the clinical trial, he needs to instill confidence in the patients in the clinical trial and with the referring physicians and with the [patients’] friends and family, to be comfortable with the company. So we updated his website, freshening the overall look and bringing the technology behind it up to date. Also, we were able to apply all of our SEO best practices throughout the site.

IBJ: SEO, or search-engine optimization, helps ImmuneWorks’ clinical-trial information to appear on the first page of Google’s search results when someone searches for IPF treatments. Why does it make sense to try to find patients using this technology, in addition to finding physicians that are already treating IPF patients?

A: IPF is fatal and there is no known treatment. The people that are diagnosed with this, they’re in desperate need of some treatment options. So they’re searching for treatment options right now. That’s why I feel that SEO makes sense for our clients.

IBJ: The new site went live 10 days ago. What’s been the response?

A: They’ve already been flooded. IPF is a pretty small population, less than 200,000 are diagnosed each year in the United States. Most of them are 60 and over. We didn’t know whether those patients would be using the Internet to research their disease. But we’re getting submissions every single day. We’ve been really pleased with the response on ImmuneWorks. The faster they can find those clinical participants the faster they can complete these clinical trails and move on to the next stage.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. I could be wrong, but I don't think Butler views the new dorm as mere replacements for Schwitzer and or Ross.

  2. An increase of only 5% is awesome compared to what most consumers face or used to face before passage of the ACA. Imagine if the Medicaid program had been expanded to the 400k Hoosiers that would be eligible, the savings would have been substantial to the state and other policy holders. The GOP predictions of plan death spirals, astronomical premium hikes and shortages of care are all bunk. Hopefully voters are paying attention. The Affordable Care Act (a.k.a Obamacare), where fully implemented, has dramatically reduced the number of uninsured and helped contained the growth in healthcare costs.

  3. So much for competition lowering costs.

  4. As I understand the proposal, Keystone would take on the debt, not the city/CRC. So the $104K would not be used to service the $3.8M bond. Keystone would do that with its share.

  5. Adam C, if anything in Carmel is "packed in like sardines", you'll have to show me where you shop for groceries. Based on 2014 population estimates, Carmel has around 85,000 people spread across about 48 square miles, which puts its density at well below 1800 persons/sq mi, which is well below Indianapolis (already a very low-density city). Noblesville is minimally less dense than Carmel as well. The initiatives over the last few years have taken what was previously a provincial crossroads with no real identity beyond lack of poverty (and the predictably above-average school system) and turned it into a place with a discernible look, feel, and a center. Seriously, if you think Carmel is crowded, couldn't you opt to live in the remaining 95% of Indiana that still has an ultra-low density development pattern? Moreover, if you see Carmel as "over-saturated" have you ever been to Chicago--or just about any city outside of Indiana?

ADVERTISEMENT